pHealth 2015: 12th International Conference on Wearable Micro and Nano Technologies for Personalized Health

pHealth 20152 - 4 June 2015, Västerås, Sweden.
The 12th International Conference on Wearable Micro and Nano Technologies for Personalized Health (pHealth) has emerged as the leading international meeting on wearable micro and nano technologies for personalized medicine. Starting in 2004, pHealth has attracted scientists for various technologies, medical doctors, and policy makers from the healthcare industry, hospital administration, and allied professionals.

Collecting a dynamic professional community from Europe and all over the world pHealth has given visibility to the tremendous potential of micro and nano technologies not only for the future of medicine, but also for the improvement of healthcare processes today. Microsystems, smart textiles, telemedicine, smart implants and sensor-controlled medical devices have become important enablers for monitoring and treatment in both inpatient and outpatient care.

This is, however, just the beginning of revolutionary changes and significant opportunities are given for patients, companies and the healthcare industry. The multilateral benefits of pHealth technologies for all stakeholders lead to a triple win situation with enormous potential, not only for medical quality improvement and industrial competitiveness, but also for managing healthcare cost. Present your pHealth solutions to the pHealth 2015 Conference and welcome you to Västerås, Sweden, to share experiences and results.

For further information and to register, please visit:
http://www.phealth2015.eu

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...